Home
Mechanism of tissue and tumor fibrosis (MOTIF)

Warning message

There has not been added a translated version of this content. You can either try searching or go to the "area" home page to see if you can find the information there

SF Fibrosis Conference, 2018

The role of the fibrotic stroma - barrier or support?

San Fransisco from Marin Headlands
Photo:
San Fransisco from Marin Headlands

Main content

SIU Fibrosis conference, June 7-8, 2018

San Francisco

Venue: Aldea conference centre, UCSF

Organizers: Donald Gullberg and Valerie Weaver

 Business meeting SIU - Upcoming student exchanges

June 7thSession 1a. Cell-ECM interactions - Chair: C. McCulloch (UoT)Notes
8.30 – 9.101. Donald Gullberg, University of Bergen
Integrin α11β1 - a fibroblast protein with a role in fibrosis
 
9.15 – 9.552. Andrew Leask, University of Western Ontario
Fibroblast-specific expression of CCN2 is required for activation of cancer asssociated-fibroblasts, angiogenesis and metastasis in a murine mode of melanoma
External
10.00-10.20Coffee 
 Session 1b. Cell-ECM interactions - Chair: D. Gullberg (UiB, UCSF) 
10.20-11.003. Christopher McCulloch, University of Toronto
Role of Flightless in Remodeling of the Fibrotic Stroma
 
11.05-11.454. Boris Hinz, University of Toronto
Macrophage-Myofibroblast (Mis-) Communication
External
11.50-12.305. Dean Sheppard, UCSF
Targeting TGFbeta-activing integrins to treat tissue fibrosis and cancer
 
12.35-13.00Lunch 
 Session 2a. Tumor stroma associated fibrosis - Chair: V. Weaver (UCSF) 
13.00-13.406. Roya Navab, University of Toronto
Desmoplasia is associated with poor prognosis and carcinoma-associated fibroblasts heterogeneity in non-small cell lung cancer
 
13.45-14.257. Valerie Weaver, UCSF
Tumor stiffness and hypoxia
 
14.30-15.058. Neil Bhowmick, Cedars Sinail Medical Centre, Los Angeles
The role of glutamine in fibroblastic activation and tumor progression
External
15.10-15.25Coffee 
 Session 2b. Tumor stroma associated fibrosis - Chair: D. Sheppard (UCSF) 
15.25-16.059. Zena Werb, UCSF
Tissue fibrosis and hypoxia in aggressive, basal-like breast cancers
 
16.10-16.5010. Tushar Desai, Stanford
Mapping Wnt signaling niches at cellular resolution in intact lung during IPF progression
External
16.55-17.30Business meeting SIU - Upcoming student exchanges
19.00Dinner for speakers and some other invited guests 
June 8thSession 3a. Mechanisms of fibrosis - Chair: B. Hinz (UoT) 
8.30 - 9.1011. Ari Molofsky, UCSF
Mesenchymal - immune crosstalk at lymphocyte tissue niches
 
9.15 - 9.5512. Yang Chen, MD Anderson Cancer Centre, Houston
Fibrosis and Cancer Metastasis
External
10.00-10.20Coffee 
 Session 3b. Mechanisms of fibrosis - Chair: R. Navab (UoT) 
10.20-10.5013. Tien Peng, UCSF
Stromal diversity and plasticity in the maintenance of organ function andfibrotic repair
 
10.55-11.3014.Tammy Chang, UCSF
The Role of Focal Adhesion Kinase in Hepatic Fibrogenesis
 
11.35-12.1015. Ori Maller, UCSF
A reciprocal interplay between tissue fibrosis and tumor immunity in breast cancer
 
12.15-13.00Lunch 
 Session 4. Emerging anti-fibrotic therapies - Chair: S. Porter (Fibrogen) 
13.00-13.4016. Bernard Coulie, Pliant Therapeutics    
Developing target engagement and inhibition tools to de-risk the clinical development of a dual selective αvβ6/αvβ1 integrin inhibitor in IPF and otherfibrotic diseases
 
13.45-14.2517. Eduard Gorina, Fibrogen
Pamrevlumab vs placebo in patients with IPF. Results of a Phase 2 Clinical Trial
 
14.30-15.1018. Kenneth E. Lipson, Fibrogen
Activity and mechanism of pamrevlumab (anti-CTGF) in a mouse radiation-induced lung fibrosis model
 
15.15-15.35Coffee

Financed: SIU